Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

Clinical trial NCT06908070 · RECRUITING

Trial details

NCT number: NCT06908070
Sponsor: Idris Bahce
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage III

Start date: 2024-12-17
Primary completion: 2026-12-17
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.